Advertisement

Pharmacy World & Science

, Volume 30, Issue 1, pp 70–72 | Cite as

Marked thrombocytosis during treatment with ceftazidime for pulmonary infection

  • Huang-Chi ChenEmail author
  • Cheng-Yuan Wang
  • Chuan-Sheng Wang
Research Article

Abstract

When an infected patient suffers from thrombocytosis, it is very difficult to identify beta-lactam antibiotic induced cases of the disease and separate these from the possibility that the disease is an acute-phase reaction in the infected patient. We present the case of a 54-year-old man who was treated with ceftazidime for pneumonia and developed thrombocytosis during the treatment course. Thrombocytosis persisted until ceftazidime was discontinued, despite clinical and radiological evidence showing that the pneumonia had greatly improved. The Naranjo probability scale indicates ceftazidime as the possible cause of the thrombocytosis in our patient. Although no obvious complications occur in most patients, we should pay close attention to the possibility of adverse reactions and evaluate whether the infection is treated with the appropriate antibiotics.

Keywords

Thrombocytosis Ceftazidime Adverse effect Pulmonary infection 

References

  1. 1.
    Frye JL, Thompson DF. Drug-induced thrombocytosis. J Clin Pharm Ther 1993;18:45–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Schafer AI. Thrombocytosis. N Engl J Med 2004;350:1211–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Aydogan T, Kanbay M, Alici O, et al. Incidence and etiology of thrombocytosis in an adult Turkish population. Platelets 2006;17:328–31.PubMedCrossRefGoogle Scholar
  4. 4.
    Parry MF, Jacobs B, Scully B, et al. Thrombocytosis: an acute-phase reactant, not an adverse reaction to the new beta-lactam antibiotics. Diagn Microbiol Infect Dis 1984;2:229–31.PubMedCrossRefGoogle Scholar
  5. 5.
    Wiwanitkit V. Extreme thrombocytosis: what are the etiologies? Clin Appl Thromb Hemost 2006;12:85–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Buss DH, Stuart JJ, Lipscomb GE. The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: an analysis of 129 cases. Am J Hematol 1985;20:365–72.PubMedCrossRefGoogle Scholar
  7. 7.
    Elliott MA, Tefferi A. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol 2005;128:275–90.PubMedCrossRefGoogle Scholar
  8. 8.
    Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–45.PubMedCrossRefGoogle Scholar
  9. 9.
    Saathoff AD, Elkins SL, Chapman SW, et al. Thrombocytosis during antifungal therapy of candidemia. Ann Pharmacother 2005;39:1238–43.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2007

Authors and Affiliations

  • Huang-Chi Chen
    • 1
    Email author
  • Cheng-Yuan Wang
    • 2
  • Chuan-Sheng Wang
    • 1
  1. 1.Division of Chest Medicine, Department of Internal MedicineKaohsiung Municipal Hsiao-Kang HospitalKaohsiungTaiwan
  2. 2.Division of Chest Medicine, Department of Internal MedicineKaohsiung Medical University HospitalKaohsiungTaiwan

Personalised recommendations